New hope for lung cancer patients with brain tumors: drug combo shows promise
Disease control
Not yet recruiting
This study tests a combination of two drugs, Sac-TMT and bevacizumab, in 50 people with a specific type of lung cancer (EGFR-mutant nonsquamous NSCLC) that has spread to the brain and stopped responding to standard targeted therapy. The goal is to see if the combination can shrin…
Phase: PHASE2 • Sponsor: Li-kun Chen • Aim: Disease control
Last updated May 08, 2026 12:01 UTC